ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003.

Yu-Peng WuWen-Cai ZhengQi HuangXu-Yun HuangFei LinZhi-Bin KeQi YouQing-Shui ZhengYong WeiXue-Yi XueNing Xu

Published in: Journal of translational medicine (2023)

ND630 could control ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003. ND630 and circKIF18B_003 may represent a novel target for prostate cancer.

Keyphrases

prostate cancer
radical prostatectomy
poor prognosis
binding protein
long non coding rna